Loading…
Login
Scholar Register
Business Register
Subscribe
Loading…
Article Title
Abstract
Keyword
Category
MESH Heading
Grant Agency
RCAID
DOI
PMID
PMCID
Author
Affiliation
Email
Journal Title
ISSN
Publisher
Loading…
Contains
Equals
Find an Article
Find an Article (55585356)
Find a Category (125)
Find a Journal (6168)
Find a Scholar (4131)
Find an Academic Assistant (18)
Find an Article PDF (4631400)
Today's Articles (347)
Subscriber (49847)
Citation(s) in
RCA
1
(from Reference Citation Analysis)
Indexed Articles
Today (0)
Yesterday (0)
This Week (0)
Last Week (0)
Current Month (0)
Last Month (0)
Ranked By
Impact Index Per Article
Citation(s) in
RCA
Results Analysis
Year Published Analysis
Article Type Analysis
Journal Title Analysis
Category Analysis
Results Analysis
Year Published
2024 (1)
Show more
Refine
Article Statistics
PubMed (1)
RCA (1)
Refine
Publication Titles
JOURNAL OF BASIC AND CLINICAL PHYSIOLOGY AND PHARMACOLOGY (1)
Show more
Refine
Category
Pharmacology & Pharmacy (1)
Physiology (1)
Show more
Refine
For:
Seetharaman R
, Pandit S, Joshi SS.
The prospective record-breaking obesity drug tirzepatide raises concerns about affordability.
J Basic Clin Physiol Pharmacol
2023;
34
:549-550. [PMID:
37326670
DOI:
10.1515/jbcpp-2023-0129
]
[
Citation(s) in
RCA
: 1
]
[
Impact Index Per Article: 1.0
]
[
Reference Citation Analysis
]
[
What about the content of this article? (
0
)
]
[
Track Full Text
]
[
Journal Information
]
[
Subscribe
]
[
Scholar Register
]
[Received: 05/12/2023]
[Accepted: 06/06/2023]
[Indexed: 06/17/2023]
Number
Cited by Other Article(s)
1
Seetharaman R
, Pandit S. Can small molecule GLP-1 agonists be the next first-line drugs in type-2 diabetes mellitus?
J Basic Clin Physiol Pharmacol
2024;
35
:1-4. [PMID:
38048046
DOI:
10.1515/jbcpp-2023-0234
]
[
Citation(s) in
RCA
: 0
]
[
Impact Index Per Article: 0
]
[
Reference Citation Analysis
]
[
Key Words
]
[
MESH Headings
]
[
Track Full Text
]
[
Journal Information
]
[
Subscribe
]
[
Scholar Register
]
[Indexed: 12/05/2023]
Abstract
Collapse
Key Words
affordability
enhanced efficacy
incretins
orforglipron
retatrutide
Collapse
MESH Headings
Humans
Diabetes Mellitus, Type 2/drug therapy
Glucagon-Like Peptide 1
Hypoglycemic Agents/pharmacology
Hypoglycemic Agents/therapeutic use
Collapse
Grants
Collapse
Affiliation(s)
Rajmohan Seetharaman
Department of Pharmacology and Therapeutics, Seth G.S. Medical College & KEM Hospital, Parel, Mumbai, India
Swarnima Pandit
Women and Child Development Commissionerate, Government of Maharashtra, Pune, India
Collapse
Page 1 of 1
1
Loading…
Loading…
Export Articles to File
Export Citation Analysis
Export Citation Analysis
Article Number From
to
A maximum of 600 records can be exported at a time.
Format:
*
Excel
Plain Text
PDF
WORD
Invalid value
Loading…
Click to Download the Exported File
Loading…
Loading…
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Select the Category
Loading…
Loading…
Impact Index Per Article
Calculation for Impact Index Per Article
Times Cited ÷ Number of Years = Impact Index Per Article
TM
Loading…